Nanobiotix S.A. (5NR)
FSX
Closed
Aug 24, 2026
Day's Range
34.0252 wk Range
6.79Overview - 5NR - Nanobiotix S.A.
Key Statistics
Valuation
Enterprise Value
1.77B
Price / Sales (TTM)
‪55.70‬
EV / EBITDA
‪-168.93‬
Profitability
Profit Margin
‪-73.51%‬
Operating Margin
‪-196.42%‬
Return on Assets
‪-10.06%‬
Return on Equity
‪28.36%‬
Ownership
Shares Outstanding
48.38M
Float
31.94M
Held by Insiders
‪15.54%‬
Held by Institutions
‪36.12%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪32.51‬
200-Day Avg
‪26.33‬
Dividends
Payout Ratio
‪0.00%‬
Peers - 5NR - Nanobiotix S.A.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 5NRFSXNanobiotix S.A.1.81BMarket Cap+78.48%52-week change—P/E (Trailing)‪-73.51%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 5NR - Nanobiotix S.A.
About
Nanobiotix S.A. is a late-stage clinical biotechnology company specializing in physics-based nanomedicines to revolutionize cancer treatment. Headquartered in Paris, France, with offices in the United States, it pioneers nanotechnology that enhances radiotherapy's efficacy. The company's lead candidate, NBTXR3…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
